Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Cash & Current Investments (2017 - 2025)

Historic Cash & Current Investments for Neuroone Medical Technologies (NMTC) over the last 11 years, with Q4 2025 value amounting to $3.6 million.

  • Neuroone Medical Technologies' Cash & Current Investments rose 21736.24% to $3.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.6 million, marking a year-over-year increase of 21736.24%. This contributed to the annual value of $6.6 million for FY2025, which is 35001.32% up from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Cash & Current Investments of $3.6 million as of Q4 2025, which was up 21736.24% from $6.6 million recorded in Q3 2025.
  • Over the past 5 years, Neuroone Medical Technologies' Cash & Current Investments peaked at $16.2 million during Q4 2021, and registered a low of $1.1 million during Q4 2024.
  • Over the past 5 years, Neuroone Medical Technologies' median Cash & Current Investments value was $5.9 million (recorded in 2023), while the average stood at $6.4 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 7256.85% in 2024, then surged by 39628.38% in 2025.
  • Quarter analysis of 5 years shows Neuroone Medical Technologies' Cash & Current Investments stood at $16.2 million in 2021, then crashed by 52.78% to $7.6 million in 2022, then crashed by 64.92% to $2.7 million in 2023, then tumbled by 57.69% to $1.1 million in 2024, then soared by 217.36% to $3.6 million in 2025.
  • Its last three reported values are $3.6 million in Q4 2025, $6.6 million for Q3 2025, and $8.0 million during Q2 2025.